Eisai R&d Management Co., Ltd.

Epizyme, Inc.

Frances Fang

Kevin Wayne Kuntz

Steven Mathieu

Arani Chanda

Kuan-Chun Huang

Kristen Sanders

Hyeong Wook Choi

Atsushi Endo

Charles E Chase

Jing Li

Provided herein is N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl (tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1&#x2032;-biphenyl]-3-carboxamide hydrobromide. Also provided herein is a particular polymorph form of this compound.

Salt form of a human histone methyltransferase EZH2 inhibitor

Provided herein is N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1&#x2032;-biphenyl]-3-carboxamide hydrobromide. Also provided herein is a particular polymorph form of this compound.

Methods of synthesizing intermediates useful for the synthesis of halichondrin B analogs are described.

Intermediates and methods for the synthesis of halichondrin B analogs

Growing community of inventors

Andover, MA, United States of America

Frances Fang